12540232

Source:http://linkedlifedata.com/resource/pubmed/id/12540232

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0243077, umls-concept:C1120843, umls-concept:C1366876
pubmed:issue	3
pubmed:dateCreated	2003-1-23
pubmed:abstractText	Imidazo[1,2-a]pyridyl N-arylpyridazinones were hybridized from the classic pyridinylimidazoles and the more recent dual hydrogen bond acceptors, resulting in a new structural class of selective p38 MAP kinase inhibitors.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/9716531
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Enzyme Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Mitogen-Activated Protein Kinases, http://linkedlifedata.com/resource/pubmed/chemical/Pyridazines, http://linkedlifedata.com/resource/pubmed/chemical/p38 Mitogen-Activated Protein...
pubmed:status	MEDLINE
pubmed:month	Jan
pubmed:issn	0022-2623
pubmed:author	pubmed-author:ChoiBernard KBK, pubmed-author:CollettiSteven LSL, pubmed-author:DixonElizabeth CEC, pubmed-author:DohertyJames BJB, pubmed-author:FitzgeraldCatherine ECE, pubmed-author:FrieJessica LJL, pubmed-author:KumarSanjeevS, pubmed-author:NicholsElizabeth AEA, pubmed-author:O'KeefeStephen JSJ, pubmed-author:O'NeillEdward AEA, pubmed-author:PorterGeneG, pubmed-author:SamuelKopparaK, pubmed-author:ScapinGiovannaG, pubmed-author:SchmatzDennis MDM, pubmed-author:SchwartzCheryl DCD, pubmed-author:ShoopWesley LWL, pubmed-author:SinghSuresh BSB, pubmed-author:ThompsonChris MCM, pubmed-author:ThompsonJames EJE, pubmed-author:WangRuixiuR, pubmed-author:WoodsAndreaA, pubmed-author:ZallerDennis MDM
pubmed:issnType	Print
pubmed:day	30
pubmed:volume	46
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	349-52
pubmed:dateRevised	2009-11-19
pubmed:meshHeading	pubmed-meshheading:12540232-Animals, pubmed-meshheading:12540232-Enzyme Inhibitors, pubmed-meshheading:12540232-Mice, pubmed-meshheading:12540232-Mitogen-Activated Protein Kinases, pubmed-meshheading:12540232-Models, Molecular, pubmed-meshheading:12540232-Pyridazines, pubmed-meshheading:12540232-Structure-Activity Relationship, pubmed-meshheading:12540232-p38 Mitogen-Activated Protein Kinases
pubmed:year	2003
pubmed:articleTitle	Hybrid-designed inhibitors of p38 MAP kinase utilizing N-arylpyridazinones.
pubmed:affiliation	Merck Research Laboratories, Merck & Co., Inc., Rahway, New Jersey 07065, USA. steve_colletti@merck.com
pubmed:publicationType	Journal Article